Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of RO6953958 in healthy participants; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• RO6953958

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Autistic Disorder, Autism Spectrum Disorder | Phase 1 | Status: COMPLETED | Results posted: 2024-07-10